Alivus Life Sciences schedules Q4 and FY2025-26 earnings call for May 15, 2026, from 8:30-9:30 AM IST.
The intimation letter to BSE and NSE includes universal and international toll-free dial-in numbers for participation.
A pre-registration link is provided, and the disclosure is signed by the Company Secretary & Compliance Officer.
The document is a standard compliance filing for an investor event with no financial data or UPSI disclosed.